In total, there were 162,873 patients with all ICD-10 coded forms of leukemia, with 5,710 (3.51%) having IDA. Furthermore, this cohort was found to be older than non-IDA leukemia patients (71.1 ± 0.45 years and 59.2 ± 0.71 years with p < 0.05, respectively). With inpatient ...
B-lymphoblastic leukemia (B-ALL) not otherwise specified (NOS; ICD-O code: 9811/3) is a neoplasm of precursorlymphoid cellscommitted to the B-cell lineage, typically composed of small to medium-size blast cells with scant cytoplasm, moderately condensed to dispersed chromatin and incons...
4j–m. As necroptosis is an immunogenic form of cell death, we further evaluated whether CLL cells acquired characteristics associated with immunogenic cell death (ICD)55 upon treatment with the SHIP1 inhibitor 3AC. Translocation of calreticulin to the surface of stressed cells acts as “eat me...
but this is impossible to differentiate as there is no code specific to that stage of the disease. To assess the effect of the inclusion of these patients on the results, a subgroup analysis was conducted to examine the overall survival and total PPPM all-cause healthcare costs only...
ITP patients were identified through an accurate algorithm (positive predictive value of 95.8% - 95% CI: 92.8 to 98.8 - in a previous validation study) using the International Classification of Diseases, tenth version (ICD-10) D69.3 code recorded as hospital discharge diagnosis or long-term ...
The analysis was based on the reimbursed prescription claims for imatinib, bosutinib, dasatinib, nilotinib, or ponatinib with the ICD-10 code C9210 in a public pharmacy between January 2009 and December 2019 using data from the National Health Insurance Fund (NHIF) of Hungar...
Methods We used the National Cancer Registry (NCR) data from 2006 to 2009 to estimate the incidence rate of CML (ICD-10 code C92.1). After adjustment for the underestimation of incidence rates, we used survival rates of CML and estimated the 5-year prevalence for these patients. In ...
We extracted Systemic Mastocytosis and Mast Cell Leukemia cases diagnosed after 20 years of age, using the ICD Code 9741/3 (SM) and 9742/3 Mast Cell Leukemia (MCL). The analysis was stratified for MCL based on age, sex, race, and treatment modality used.Results:A total of 795 cases ...
Methods: Electronic medical record data from the Veterans Affairs Corporate Data Warehouse was used to identify patients with an ICD 9 or 10 code for ALL. All patients were chart checked to confirm ALL diagnosis and excluded if they were diagnosed before 2000, had childhood ALL, or if ...
Patients were included if they have at least one claim with CML ICD-10 code during April 2010. Repeated records were excluded using ide ntification code, age, sex, and diagnosis date as compatibility criteria. Kruskal-Wallis test was used to compare clinical and demographical variables and cost...